Harvard Bioscience (HBIO) Other financing activities (2020 - 2026)
Harvard Bioscience (HBIO) posted quarterly Other financing activities of $150000.0 for Q1 2026, up 14900.0% quarter-over-quarter from $1000.0 in Q4 2025.
Harvard Bioscience (HBIO) Other financing activities (2020 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Other financing activities for 7 consecutive years, with $150000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $150000.0; the TTM figure through Mar 2026 stood at $197000.0 (down 46.03% YoY), while the FY2025 annual figure was $47000.0, down 87.63% from the prior year.
- Other financing activities rose to $150000.0 in Q1 2026 per HBIO's latest filing, from $1000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $620000.0 in Q2 2023 and bottomed at $1000.0 in Q4 2025.
- Historically, Other financing activities has averaged $148857.1 across 5 years, with a median of $127000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other financing activities surged 235.48% — and 2025, when it tumbled 99.38%.
- Harvard Bioscience's Other financing activities stood at $231000.0 in 2022, then dropped by 10.82% to $206000.0 in 2023, then dropped by 21.84% to $161000.0 in 2024, then sank by 99.38% to $1000.0 in 2025, then surged by 14900.0% to $150000.0 in 2026.
- Business Quant data shows HBIO's Other financing activities at $150000.0 in Q1 2026, $1000.0 in Q4 2025, and $46000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Dec 31, 2024 | 161,000.00 |
| Dec 31, 2024 | 161,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 189,000.00 |
| Jun 30, 2024 | 189,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Jun 30, 2023 | 620,000.00 |
| Jun 30, 2023 | 620,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Mar 31, 2023 | 104,000.00 |